Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LY 191145

Known as: LY-191145, LY191145 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
LY191145 is an N-alkylated glycopeptide antibiotic (the p-chlorobenzyl derivative of LY264826) with activity against vancomycin… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
The widespread appearance of methicillin resistant Staphylococcus aureus (MRSA) has significantly undermined the efficacy of… Expand
Is this relevant?
1996
1996
LY191145 is a p-chlorobenzyl derivative of LY264826 (A82846B) with activity against both vancomycin-susceptible and -resistant… Expand
Is this relevant?
1995
1995
LY191145 is the prototype of a series of compounds with activities against vancomycin-resistant enterococci derived by… Expand
Is this relevant?
1995
1995
Bactericidal activities of LY191145, an investigational glycopeptide, and vancomycin against Staphylococcus aureus were evaluated… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?